Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
03/1995
03/30/1995WO1995008549A1 3-(5-tetrazolyl-benzyl)amino-piperidine derivatives and antagonists of tachykinins
03/30/1995WO1995008540A1 Bis(amidinobenzimidazolyl)alkanes as antiviral agents
03/30/1995WO1995008534A1 3-(3,4-dioxyphenyl)-pyrrolidines as type iv phosphodiesterase inhibitors for the treatment of inflammatory diseases
03/30/1995WO1995008462A1 Hydraulic system for anti-lock braking installations in motor vehicles
03/30/1995WO1995008343A1 Modified truncated complement system regulators
03/30/1995WO1995008337A1 Use of angiotensin iii and analogs thereof in tissue repair
03/30/1995WO1995008331A1 Enteric coated oral compositions containing bisphosphonic acid derivatives
03/30/1995CA2172529A1 3-(5-tetrazolyl-benzyl)amino-piperidine derivatives and antagonists of tachykinins
03/30/1995CA2172494A1 Use of angiotensin ii analogs in tissue repair
03/30/1995CA2172158A1 Treatment of immunologic and hematologic disorders with igfbp alone or complexed with igf
03/30/1995CA2171448A1 3-(3,4-dioxyphenyl)-pyrrolidines as type iv phosphodiesterase inhibitors for the treatment of inflammatory diseases
03/29/1995EP0645391A2 Aminobenzoic acid derivatives
03/29/1995EP0645390A1 Trisubstituted pyrimido 5,4-d pyrimidines for modulating multidrug resistance, drugs containing these compounds and processes for their preparation
03/29/1995EP0645378A1 Condensed seven- or eight-membered heterocyclic compounds useful as squalene synthetase inhibitors
03/29/1995EP0645377A1 Benzoxazepine derivatives useful as squalene synthetase inhibitors
03/29/1995EP0645376A1 Substituted 1-phenyl-oxazolidin-2-one derivatives, their preparation and their use as adhesion-receptor antagonists
03/29/1995EP0645137A1 Use of quinones for the manufacture of a medicament for the treatment and prevention of a allergic rhinitis
03/29/1995EP0644933A1 Constitutive and inducible epidermal vector systems
03/29/1995EP0644889A1 COMPOSITIONS AND METHODS FOR MODULATING $g(b)-AMYLOID
03/29/1995EP0644882A1 Novel piperzinyl-bis(alkylamino)pyrimidine derivatives and process for preparing same
03/29/1995EP0644877A1 Substituted-hexahydrobenzo a]phenanthridines
03/29/1995EP0644770A1 Stabilized somatotropin for parenteral administration
03/29/1995EP0644765A1 Treatment of cellular hyperproliferation by inhibition of interleukin-1
03/29/1995EP0569411B1 Acylamino-alkyliden-hydroxy-bisphosphonic acids useful in the therapy of osteoarticular diseases
03/29/1995EP0558563B1 Anti-inflammatory compounds
03/29/1995EP0535042B1 Angiotensis converting enzyme inhibitors
03/29/1995CN1100724A 5-acylamino-1,2,4-thiadiazoles, their preparation and pharmaceutical compositions containing them
03/29/1995CN1100721A Imidazopyridine
03/29/1995CN1100633A Chondroprotective agents
03/29/1995CN1100631A Chondroprotective agents
03/28/1995US5401875 2-aminocarboxylic acids and their derivatives, processes for their preparation and their use as medicaments
03/28/1995US5401851 Preparation of proline derivatives
03/28/1995US5401758 For treating ischemia
03/28/1995US5401754 Agent for treating thrombosis and phosphodiesterase inhibitor
03/28/1995US5401750 Derivatives of substituted imidazol-2-one and process for their preparation
03/28/1995US5401748 2,14-disubstituted ergolines, their production and use in pharmaceutical compositions
03/28/1995US5401743 Aminoalkyl-substituted 2-amino-5-mercaptothiadiazoles the preparation and use thereof
03/28/1995US5401738 Benzimidazole compounds
03/28/1995US5401727 Process for enhancing the resistance of aquatic animals to disease
03/28/1995CA2078214C Benzylphosphonic acid tyrosine kinase inhibitors
03/28/1995CA1334975C Furan and pyrrole containing lipoxygenase inhibiting compounds
03/28/1995CA1334972C Pyridine-2,4- and -2,5-dicarboxylic acid amides, processes for their preparation, the use thereof, and medicaments based on these compounds
03/28/1995CA1334969C Substituted dihydroisoquinoline and phthalazine derivatives as potentiators of the lethal effects of radiation and certain chemotherapeutic agents, selected compounds, analogs andprocess
03/28/1995CA1334967C Pharmacologically active compounds, methods for the preparation thereof and compositions containing the same
03/27/1995EP0660836A4 Tricyclic derivatives of the thienodiazocine and thienothiadiazocine classes of compounds.
03/25/1995WO1999013871A2 Fused imidazole derivatives for improving oral bioavailability of pharmaceutical agents
03/25/1995CA2132794A1 Condensed 7-membered cyclic compounds and their use
03/25/1995CA2132792A1 Condensed cyclic compounds and their use
03/24/1995CA2132579A1 Adhesion receptor antagonists iii
03/23/1995WO1995007994A2 Recombinant alphavirus vectors
03/23/1995WO1995007982A1 Activin receptors-like kinase (alk), belonging to the tgf receptor family and/or to the bmp receptor family
03/23/1995WO1995007934A2 Il8 inhibitors
03/23/1995WO1995007927A1 Androstenone derivative
03/23/1995WO1995007926A1 Androstenones
03/23/1995WO1995007917A1 5-(1-fluoro-vinyl)-1h-pyrimidine-2,4-dione derivatives useful as antineoplastic agents
03/23/1995WO1995007904A1 Imidazolone and oxazolone derivatives as dopamine antagonists
03/23/1995WO1995007899A1 3,4-dihydro-2h-1,2,4-benzothiadiazine 1,1-dioxide-3-carboxylic acid derivatives, their preparation and drugs containing same
03/23/1995WO1995007898A1 Succinamic acid compound, process for producing the same, and use thereof
03/23/1995WO1995007893A1 Fused tricyclic heteroaromatic derivatives as dopamine receptor subtype ligands
03/23/1995WO1995007886A1 3-amino-5-carboxy-substituted piperidines and 3-amino-4-carboxy-substituted pyrrolidines as tachykinin antagonists
03/23/1995WO1995007885A1 Derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene active on the cardiovascular system
03/23/1995WO1995007716A1 Pharmaceutical composition comprising monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon
03/23/1995WO1995007711A1 Therapeutic treatment for inhibiting blood vessel blockage using a polypeptide
03/23/1995WO1995007701A1 Oral water soluble pharmaceutical compositions containing estrone derivative and calcium salt
03/23/1995WO1995007700A1 Method for protection against genotoxic mutagenesis
03/23/1995WO1995007697A2 Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus
03/23/1995WO1995007696A1 Pharmaceutical composition of hiv-protease inhibitors
03/23/1995WO1995007694A1 Use of thiazolidinediones to prevent or delay onset of niddm
03/23/1995WO1995005364A3 Inhibitors of biogenic amine transporters
03/23/1995WO1995003333A3 Tryptase inhibitor
03/23/1995WO1994028897A3 Use of an mhc class i suppressor drug for the treatment of autoimmune diseases and transplantation rejection
03/23/1995DE4332041A1 Use of pentoxifylline for the treatment of granulomatous and fibrotic pulmonary disorders
03/23/1995CA2462061A1 Androstenone derivative
03/23/1995CA2171955A1 Pharmaceutical composition comprising monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon
03/23/1995CA2171829A1 Oral water soluble pharmaceutical compositions containing estrone derivative and calcium salt
03/23/1995CA2171756A1 Succinamic acid compound, production method thereof and use thereof
03/23/1995CA2170619A1 Derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene active on the cardiovascular system
03/23/1995CA2170405A1 Activin receptors-like kinase (alk), belonging to the tgf receptor family and/or to the bmp receptor family
03/23/1995CA2168751A1 Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus
03/23/1995CA2168740A1 Imidazolone and oxazolone derivatives as dopamine antagonists
03/23/1995CA2168739A1 Fused tricyclic heteroaromatic derivatives
03/23/1995CA2167412A1 Pharmaceutical composition of hiv-protease inhibitors
03/23/1995CA2132608A1 Pro-prodrugs, their production and use
03/22/1995EP0644198A1 Alpha-heteroaryloxymethyl ketones as interleukin-1beta converting enzyme inhibitors
03/22/1995EP0644181A1 Amino acid derivative and use thereof
03/22/1995EP0643972A2 Use of recombinant colony stimulating factor-1 for the preparation of a medicament for cytomegalovirus infections and leukopenia
03/22/1995EP0643780A1 Multiple solvent cleaning system.
03/22/1995EP0643775A1 Therapeutic compositions
03/22/1995EP0643767A1 Osteogenic peptides
03/22/1995EP0643728A1 Icam-related protein
03/22/1995EP0643726A1 PEPTIDES OF HUMAN p53 PROTEIN FOR USE IN HUMAN T CELL RESPONSE INDUCING COMPOSITIONS, AND HUMAN p53 PROTEIN-SPECIFIC CYTOTOXIC T-LYMPHOCYTES
03/22/1995EP0643725A1 Single chain peptide compounds having hemoregulatory activity
03/22/1995EP0643716A1 Quaternary nitrogen-containing phosphonate compounds for treating abnormal calcium and phosphate metabolism
03/22/1995EP0643686A1 New compounds
03/22/1995EP0495877B1 Methods and compositions for healing bone
03/22/1995EP0301087B1 Peptide
03/22/1995CN1100417A N-heteroaryl-n'-phenylurea derivatives, their production and use
03/22/1995CN1100416A Derivative of 2-amino-N-ÛÛÛ4-(aminocarbonyl)pyrimidin-2-ylÙamizoÙalkylÙpyrimidiny-4-carboxamide, preparation and pharmaceutical application of same
03/22/1995CN1100414A Preparation of pharmaceutical compound containing novel derivative of leukol
03/22/1995CN1100413A Urethanes and ureas that induce cytokine production
1 ... 1408 1409 1410 1411 1412 1413 1414 1415 1416 1417 1418 1419 1420 1421 1422 1423 1424 1425 1426 1427 1428 ... 1564